Global QSAR modeling of LogP values of phenethylamines acting as adrenergic alpha-1 receptor agonists

Global QSAR models predict biological response of molecular structures which are generic in particular class. A global QSAR dataset admits structural features derived from larger chemical space, intricate to model but more applicable in medicinal chemistry. The present work is global in either sense of structural diversity in QSAR dataset or large number of descriptor input. Forty phenethylamine structure derivatives were selected from a large pool (904) of similar phenethylamines available in Pubchem database. LogP values of selected candidates were collected from physical properties database (PHYSPROP) determined in identical set of conditions. Attempts to model logP value have produced significant QSAR models. MLR aided linear one-variable and two-variable QSAR models with their respective R2 (0.866, 0.937), R2A (0.862, 0.932), F-stat (181.936, 199.812) and Standard Error (0.365, 0.255) are statistically fit and found predictive after internal validation and external validation. The descriptors chosen after improvisation and optimization reveal mechanistic part of work in terms of Verhaar model of Fish base-line toxicity from MLOGP, i.e. (BLTF96) and 3D-MoRSE -signal 15 /unweighted molecular descriptor calculated by summing atom weights viewed by a different angular scattering function (Mor15u) are crucial in regulation of logP values of phenethylamines.

[1]  K. Minneman,et al.  Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes. , 1994, Molecular pharmacology.

[2]  Ron Kohavi,et al.  Wrappers for Feature Subset Selection , 1997, Artif. Intell..

[3]  Mark T. D. Cronin,et al.  Toxicological Information for Use in Predictive Modeling: Quality, Sources, and Databases , 2005 .

[4]  P. Amouyel,et al.  Overweight and obesity: a major challenge for coronary heart disease secondary prevention in clinical practice in Europe. , 2000, European heart journal.

[5]  C. Hague,et al.  The N Terminus of the Human α1D-Adrenergic Receptor Prevents Cell Surface Expression , 2004, Journal of Pharmacology and Experimental Therapeutics.

[6]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[7]  P. Smid,et al.  Structure–Activity Relationships of Phenylalkylamines as Agonist Ligands for 5‐HT2A Receptors , 2008, ChemMedChem.

[8]  A. Naylor,et al.  Characterization of an α1D‐adrenoceptor mediating the contractile response of rat aorta to noradrenaline , 1995, British journal of pharmacology.

[9]  J. Staessen,et al.  Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention , 2005, Hypertension.

[10]  A. Hatano,et al.  Pharmacological evidence of distinct oci‐adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery , 1994, British journal of pharmacology.

[11]  C. Chapple,et al.  The role of capacitative Ca2+ influx in the αlB‐adrenoceptor‐mediated contraction to phenylephrine of the rat spleen , 1995, British journal of pharmacology.

[12]  G. Dorn,et al.  Adrenergic signaling polymorphisms and their impact on cardiovascular disease. , 2010, Physiological reviews.

[13]  Ovanes Mekenyan,et al.  Global modeling of narcotic chemicals: ciliate and fish toxicity , 2003 .

[14]  I. Marshall,et al.  Noradrenaline contractions of human prostate mediated by α1c‐(α1c‐) adrenoceptor subtype , 1995 .

[15]  J. Thurmon,et al.  Alpha adrenoceptor pharmacology. , 1984, Journal of the American Veterinary Medical Association.

[16]  B. Bhattarai,et al.  Comparison of bolus phenylephrine, ephedrine and mephentermine for maintenance of arterial pressure during spinal anesthesia in cesarean section. , 2010, JNMA; journal of the Nepal Medical Association.